INO stock

Inovio Pharmaceuticals Inc (INO) financials · rev $65.3K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Inovio Pharmaceuticals Inc (INO) rev $65.3K.

Cached annual income statement
LineFY2025FY2024
Revenue$65.3K$217.8K
Operating Income-$86.8M-$112.4M
Net Income-$84.9M-$107.3M
EPS (Diluted)-$1.81-$3.95
Cached annual balance sheet
LineFY2025FY2024
Total Assets$74.3M$113.2M
Current Assets$61.1M$97.8M
Cash & Equivalents$44.3M$65.8M
PP&E$2.53M$3.66M
Total Liabilities$50.2M$44.7M
Current Liabilities$43.7M$35.3M
Shareholders' Equity$24.1M$68.5M
Retained Earnings-$1.82B-$1.73B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$88.6M-$104.1M
CapEx$285.7K$487.8K
Investing Cash Flow$14.0M$104.1M
Financing Cash Flow$53.1M$51.5M
Net Change in Cash-$21.5M$51.5M
Free Cash Flow-$88.9M-$104.6M
These statements as JSON? API free 100/day

FAQ

What is INO P/E and revenue?

Inovio Pharmaceuticals Inc (INO) rev $65.3K.

What is INO revenue?

Inovio Pharmaceuticals Inc last cached revenue is $65.3K (FY2025).

Is INO profitable?

Inovio Pharmaceuticals Inc last cached net income is -$84.9M (FY2025).

What are INO total assets?

Inovio Pharmaceuticals Inc last cached total assets are $74.3M (FY2025).

What is INO free cash flow?

Inovio Pharmaceuticals Inc last cached free cash flow is -$88.9M (FY2025).

Not investment advice. Cached statements, not a live tape.